COVID-19 vaccine weekly safety report (25 November 2021)


25 November 2021 - To 21 November 2021, the TGA has received 341 reports which have been assessed as likely to be myocarditis from about 23.9 million doses of Comirnaty (Pfizer).

One new case of thrombosis with thrombocytopenia syndrome was reported this week, taking the total to 164 cases from about 13.4 million doses of Vaxzevria (AstraZeneca).

Read TGA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Vaccine , Safety , COVID-19